KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Resmed (RMD) Current Leases (2019 - 2025)

Resmed (RMD) has disclosed Current Leases for 7 consecutive years, with $29.8 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Current Leases rose 7.0% year-over-year to $29.8 million, compared with a TTM value of $29.8 million through Dec 2025, up 7.0%, and an annual FY2025 reading of $30.5 million, up 20.68% over the prior year.
  • Current Leases was $29.8 million for Q4 2025 at Resmed, down from $30.0 million in the prior quarter.
  • Across five years, Current Leases topped out at $30.5 million in Q2 2025 and bottomed at $21.1 million in Q3 2022.
  • Average Current Leases over 5 years is $24.9 million, with a median of $24.0 million recorded in 2021.
  • The sharpest move saw Current Leases decreased 8.04% in 2022, then grew 29.75% in 2024.
  • Year by year, Current Leases stood at $23.9 million in 2021, then fell by 6.2% to $22.4 million in 2022, then increased by 7.26% to $24.1 million in 2023, then increased by 15.61% to $27.8 million in 2024, then increased by 7.0% to $29.8 million in 2025.
  • Business Quant data shows Current Leases for RMD at $29.8 million in Q4 2025, $30.0 million in Q3 2025, and $30.5 million in Q2 2025.